Evaluation of maternal serum sestrin-2 levels in intrauterine growth restriction.
Merve Ozturk AgaogluZahid AgaogluKadriye Yakut YucelFiliz Halıcı OzturkTurhan CaglarPublished in: Irish journal of medical science (2023)
Maternal serum SESN2 levels are elevated in IUGR and are associated with adverse neonatal outcome. Considering that SESN2 is involved in pathogenesis, it can be used as a new marker for the evaluation of IUGR.